EUCTR2005-002181-11-IT进行中（未招募）不适用
FOLFIRI vs XELIRI in the treatment of advanced colo-rectal untreated carcinoma: a phase II randomized study of the Gruppo Oncologico dell'Italia Meridionale - ND
OSPEDALE ONCOLOGICO DI BARI0 个研究点开始时间: 2007年7月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Locally advanced or metastatic colo-rectal carcinoma
- •2. Presence of at least one measurable lesion
- •3. Age between 18 and 75 years
- •4. Life expectancy >= 3 months
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Brain metastasis
- •2. Previous chemotherapy for locally advanced or metastatic colo-rectal carcinoma
- •3. Pregnancy and breast-feeding
- •4. Any other contemporary tumour
研究者
相似试验
Unknown
2 期
High-dose FOLFIRI in Advanced Colorectal Cancer Patients With Wild-type UGT1A1*6 and *28Colorectal CancerNCT03329183Shanghai Changzheng Hospital90
招募中
2 期
PhaseII study of Combination FOLFIRI with Cetuximab in patients with advanced/metastatic colorectal cancer previously received oxaliplatin-based chemoterapy.Colorectal CancerJPRN-UMIN000007372Kurume University School of medicine, Department of Surgery30
已完成
1 期
Phase I study of FOLFOXIRI+Bev for unresectabl colorecatal cancernresectable colorectal cancerJPRN-UMIN000010442Aichi Cancer Center Hospital20
已完成
不适用
The efficacy and safety of FOLFOXIRI for unresectable advanced rectal cancer : a prospective observational studyJPRN-UMIN000040275Kanagawa Cancer Center20
Unknown
2 期
wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer PatientsColorectal CancerNCT01736904Fudan University100